Search

Home > Diabetes Knowledge into Practice Podcast > Selecting between agents: What do the data tell us? | With Prof. Tina Vilsbøll
Podcast: Diabetes Knowledge into Practice Podcast
Episode:

Selecting between agents: What do the data tell us? | With Prof. Tina Vilsbøll
Category: Health
Duration: 00:18:15
Publish Date: 2021-11-30 05:00:00
Description:

This week we’re joined by Prof. Tina Vilsbøll to discuss how different second-line agents for type 2 diabetes compare, and what we should consider when selecting between them. Listen for a summary of what the data tells us about GLP-1 RAs, SGLT2is and DPP-4is.

We’ve got a new website! Find it at diabetes.knowledgeintopractice.com, where you can see all past episodes of the podcast as well as other free CME resources. Follow us on Twitter (@dkipractice) or connect on LinkedIn.

Disclosures:

Prof. Tina Vilsbøll declares the following:  

Consultant, ad. board: Astra, Novo, BMS, Merck, Lilly, Sanofi; Gilead, Sunpharma, Boehringer, Mundipharma

All conflicts of interest have been mitigated prior to this activity.

Target Audience

This educational activity is intended for an international audience of non-US and non-UK HCPs.

Funding

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.
Total Play: 0